Is Cipher Pharmaceuticals Inc halal to invest in?

As of July 2026, Cipher Pharmaceuticals Inc CPH.TO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.

Is Cipher Pharmaceuticals Inc a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cipher Pharmaceuticals Inc using these criteria to determine its compliance status.

Can Muslims buy shares of Cipher Pharmaceuticals Inc?

Muslim investors may consider investing in Cipher Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Cipher Pharmaceuticals Inc classified as HALAL?

Musaffa determines the Shariah status of Cipher Pharmaceuticals Inc by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Cipher Pharmaceuticals Inc updated?

The Shariah compliance status of Cipher Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Cipher Pharmaceuticals Inc become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Cipher Pharmaceuticals Inc?

You can check the latest Shariah compliance status of Cipher Pharmaceuticals Inc on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Cipher Pharmaceuticals Inc CPH.TO

Last Updated: Jul 22, 12:00 AM·TSX

CPH.TO Shariah Compliance

Screening Methodology: AAOIFI

As of July 2026, Cipher Pharmaceuticals Inc is classified as halal.

HALAL

Report Source: 2026 1st Quarter Report

Cipher Pharmaceuticals Inc. Stock Analysis CPH.TO

Canada Health Care Small Cap Report: Q1, 2026

Cipher Pharmaceuticals, Inc. engages in a diversified portfolio of commercial and early to late-stage products. The company is headquartered in Mississauga, Ontario and currently employs 43 full-time employees. The company went IPO on 2004-02-25. The firm acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and markets those products in Canada, the United States, and South America. Its dermatology products include Actikerall, Epuris, Vaniqa and Natroba. Its hospital acute care products include Aggrastat and Brinavess. Its out-licensed products include Absorica, ConZip and Lipofen. Durela is its specialty medicine. Its product pipeline includes MOB-015, CF-101, and DTR-001. The company delivers novel products to healthcare professionals and patients in Canada in a range of therapeutic areas, including dermatology, women’s health, urology and others. Its Natroba (spinosad) Topical Suspension is indicated for the topical treatment of head lice and scabies infestations in adult and pediatric patients.

Key Statistics of Cipher Pharmaceuticals Inc (CPH.TO)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

CAD16.34CAD16.84

Today's Open

CAD16.84

Volume

9804.00

P/E Ratio (TTM)

10.92

52 Week Range

CAD11.98CAD20.56

Market Cap

440.03M

Avg. Volume

13.33K

Dividend Yield

Financial Metrics & Statements of Cipher Pharmaceuticals Inc (CPH.TO)

Super Investors Invested in Cipher Pharmaceuticals Inc (CPH.TO)

FAQ's for Cipher Pharmaceuticals Inc (CPH.TO)

As of July 2026, Cipher Pharmaceuticals Inc CPH.TO is classified as halal according to Musaffa’s Shariah screening methodology. This classification is based on an assessment of the company’s business activities and financial ratios against Islamic investment guidelines.
A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Cipher Pharmaceuticals Inc using these criteria to determine its compliance status.
Muslim investors may consider investing in Cipher Pharmaceuticals Inc if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
Musaffa determines the Shariah status of Cipher Pharmaceuticals Inc by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
The Shariah compliance status of Cipher Pharmaceuticals Inc may be updated periodically when new financial statements, earnings reports, or business activity information become available.
Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
You can check the latest Shariah compliance status of Cipher Pharmaceuticals Inc on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.